Skip to main content
Caplight Logo









OxSonics Therapeutics

OxSonics Therapeutics

Private
OxfordHealthcare & Life Scienceshttps://oxsonics.com/

Last Round

Series B

Extension

Jul 1, 2020

Total Funding Raised

$25.48M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

OxSonics Therapeutics is a clinical-stage medtech company that develops ultrasound-based drug delivery platforms to enhance the efficacy of oncology treatments for solid tumors.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Medical Imaging

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

ultrasound drug deliverysolid tumor treatmentSonoTrandrug delivery platformacoustic cavitationpassive acoustic mappingoncology devicemedtechmedical ultrasounddrug penetrationtherapeutic agent deliverybiotechcancer therapysee-as-you-treat

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OxSonics Therapeutics Comparables

Compare OxSonics Therapeutics with similar companies based on industry and business-model similarity.

OxSonics Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
IMGT Co., Ltd.
83%
Carthera
82%
Cordance Medical
77%

OxSonics Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionJul 1, 2020
SeedJan 1, 2014

Key People

Founding team and executive leadership

Constantin Coussios OBE FREng FMedSci

Founder & Director, Chief Scientific Officer

Founding Team

OxSonics Therapeutics Investors

Notable investors and investment history

OxSonics Therapeutics investors
InvestorRounds
Perivoli InnovationsSeries B Extension
Oxford University InnovationSeries B, Seed
MMK CapitalSeries B Extension
Oxford Technology and Innovations EIS FundSeries B Extension
Longwall Venture PartnersSeries B Extension, Series B, Seed
National Institute for Health and Care ResearchGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Monthly visitors increased 1413% MoM.

  • Jun 2, 2025

    Monthly visitors increased 80% MoM.

OxSonics Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OxSonics Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OxSonics Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersOxford
Employee Range15
Year Founded2013
Last FundingJul 1, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?